Federated Hermes, Inc. 13D and 13G filings for Regulus Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-18 10:25 am Purchase | 2023-12-31 | 13G | Regulus Therapeutics Inc. RGLS | FEDERATED HERMES INC. FHI | 4,023,860 19.900% | 148,282 (+3.83%) | Filing |
| 2023-05-10 09:58 am Purchase | 2023-04-30 | 13G | Regulus Therapeutics Inc. RGLS | FEDERATED HERMES INC. FHI | 3,875,578 19.900% | 970,752 (+33.42%) | Filing |
| 2023-02-01 11:43 am Sale | 2022-12-31 | 13G | Regulus Therapeutics Inc. RGLS | FEDERATED HERMES INC. FHI | 2,904,826 17.250% | -1 (-0.00%) | Filing |
| 2022-05-16 2:35 pm Purchase | 2022-04-30 | 13G | Regulus Therapeutics Inc. RGLS | FEDERATED HERMES INC. FHI | 2,904,827 19.900% | 2,904,827 (New Position) | Filing |